These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 550288)

  • 21. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G; Kobayashi GS
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract]   [Full Text] [Related]  

  • 22. Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity.
    Roselle GA; Kauffman CA
    Clin Exp Immunol; 1980 Apr; 40(1):186-92. PubMed ID: 6993075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of chromoblastomycosis with a new method].
    Bopp C
    Med Cutan Ibero Lat Am; 1976; 4(4):285-92. PubMed ID: 798082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
    Park SG; Oh SH; Suh SB; Lee KH; Chung KY
    Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK; Pankiewicz IJ
    Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH; Andrews FA; Sarosi GA
    Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
    Schwarz P; Janbon G; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2007 Jan; 51(1):383-5. PubMed ID: 17043122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
    Hironaga M; Mochizuki T; Watanabe S
    Mycopathologia; 1982 Aug; 79(2):101-4. PubMed ID: 6290889
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
    Chin CS; Cheong YM; Wong YH
    Med J Malaysia; 1989 Sep; 44(3):194-8. PubMed ID: 2696871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
    Kitahara M; Seth VK; Medoff G; Kobayashi GS
    Antimicrob Agents Chemother; 1976 Jun; 9(6):915-9. PubMed ID: 820247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function.
    Roselle GA; Kauffman CA
    Antimicrob Agents Chemother; 1978 Sep; 14(3):398-402. PubMed ID: 708017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphotericin B and 5-fluorocytosine penetration into blood and fibrin clots.
    Rubinstein E
    Chemotherapy; 1979; 25(5):249-53. PubMed ID: 573195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).
    Marks MI; Steer P; Eickhoff TC
    Appl Microbiol; 1971 Jul; 22(1):93-5. PubMed ID: 5165106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B].
    Polak A
    Mykosen; 1987 Jul; 30(7):306-8, 311-4. PubMed ID: 3657853
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro susceptibility of Paracoccidioides brasiliensis yeast form to antifungal agents.
    Restrepo A; Tabares Cde B
    Rev Inst Med Trop Sao Paulo; 1984; 26(6):322-8. PubMed ID: 6100138
    [No Abstract]   [Full Text] [Related]  

  • 40. Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
    Corrado ML; Kramer M; Cummings M; Eng RH
    Sabouraudia; 1982 Jun; 20(2):109-13. PubMed ID: 6287653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.